Surging 2026 U.S. measles cases, already at 2,566 confirmed reports as of August 13 per CDC surveillance, reflect sustained transmission in under-vaccinated communities, with 94% of cases outbreak-associated and 93% occurring among unvaccinated individuals. This exceeds the full-year 2025 total of 2,289 and marks the highest annual count in over three decades, driven by declining routine immunization coverage, ongoing chains from 2025 outbreaks, and imported cases seeding new clusters across 47 jurisdictions. CDC data show 7% hospitalization so far, with weekly updates and potential back-to-school transmission risks as key near-term monitoring points that could shift totals before year-end resolution. Historical baselines of under 300 annual cases pre-2024 underscore how current epidemiological conditions favor continued growth absent rapid vaccination uptake.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoPrzypadki odry w USA w 2026 roku?
Przypadki odry w USA w 2026 roku?
$7,830,948 Wol.
$7,830,948 Wol.
Dec 31, 2026
↑4.5k
42%
↑3k
95%
↑3.5k
93%
↑4k
75%
↑5k
26%
↑7,5 tys.
12%
↑10k
6%
↑12,5 tys.
5%
$7,830,948 Wol.
$7,830,948 Wol.
Dec 31, 2026
↑4.5k
$20 Wol.
42%
↑3k
$90,114 Wol.
95%
↑3.5k
$13,530 Wol.
93%
↑4k
$220,549 Wol.
75%
↑5k
$230,428 Wol.
26%
↑7,5 tys.
$185,031 Wol.
12%
↑10k
$6,515,593 Wol.
6%
↑12,5 tys.
$349,917 Wol.
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Surging 2026 U.S. measles cases, already at 2,566 confirmed reports as of August 13 per CDC surveillance, reflect sustained transmission in under-vaccinated communities, with 94% of cases outbreak-associated and 93% occurring among unvaccinated individuals. This exceeds the full-year 2025 total of 2,289 and marks the highest annual count in over three decades, driven by declining routine immunization coverage, ongoing chains from 2025 outbreaks, and imported cases seeding new clusters across 47 jurisdictions. CDC data show 7% hospitalization so far, with weekly updates and potential back-to-school transmission risks as key near-term monitoring points that could shift totals before year-end resolution. Historical baselines of under 300 annual cases pre-2024 underscore how current epidemiological conditions favor continued growth absent rapid vaccination uptake.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Rynek otwarty: Feb 16, 2026, 11:51 AM ET
Wolumen
$7,830,948Data zakończenia
Dec 31, 2026Rynek otwarty
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Surging 2026 U.S. measles cases, already at 2,566 confirmed reports as of August 13 per CDC surveillance, reflect sustained transmission in under-vaccinated communities, with 94% of cases outbreak-associated and 93% occurring among unvaccinated individuals. This exceeds the full-year 2025 total of 2,289 and marks the highest annual count in over three decades, driven by declining routine immunization coverage, ongoing chains from 2025 outbreaks, and imported cases seeding new clusters across 47 jurisdictions. CDC data show 7% hospitalization so far, with weekly updates and potential back-to-school transmission risks as key near-term monitoring points that could shift totals before year-end resolution. Historical baselines of under 300 annual cases pre-2024 underscore how current epidemiological conditions favor continued growth absent rapid vaccination uptake.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Wolumen
$7,830,948Data zakończenia
Dec 31, 2026Rynek otwarty
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...Surging 2026 U.S. measles cases, already at 2,566 confirmed reports as of August 13 per CDC surveillance, reflect sustained transmission in under-vaccinated communities, with 94% of cases outbreak-associated and 93% occurring among unvaccinated individuals. This exceeds the full-year 2025 total of 2,289 and marks the highest annual count in over three decades, driven by declining routine immunization coverage, ongoing chains from 2025 outbreaks, and imported cases seeding new clusters across 47 jurisdictions. CDC data show 7% hospitalization so far, with weekly updates and potential back-to-school transmission risks as key near-term monitoring points that could shift totals before year-end resolution. Historical baselines of under 300 annual cases pre-2024 underscore how current epidemiological conditions favor continued growth absent rapid vaccination uptake.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania